TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Yestar Healthcare Holdings Co Ltd ( (HK:2393) ) just unveiled an update.
Yestar Healthcare Holdings Co Ltd has announced plans to form a joint venture in Singapore with New Genetron Holding Limited, focusing on establishing clinical molecular diagnostics laboratories in Indonesia. The venture aims to advance precision oncology by offering services like early cancer screening and comprehensive genomic profiling, leveraging Genetron Health’s technology. This strategic move is expected to enhance Yestar’s market presence in Southeast Asia and foster partnerships with Indonesian healthcare institutions, potentially impacting the company’s operational scope and industry positioning.
More about Yestar Healthcare Holdings Co Ltd
Yestar Healthcare Holdings Co Ltd is primarily engaged in the distribution of in vitro diagnostic (IVD) products in the cities of the People’s Republic of China (PRC). The company also manufactures medical films for imaging technologies such as X-Ray, MRI, and CT-scan for Fujifilm in the PRC, and produces dental film and medical dry film products under its own brand ‘Yes!Star’.
Average Trading Volume: 4,996,847
Technical Sentiment Signal: Hold
Current Market Cap: HK$295.9M
See more data about 2393 stock on TipRanks’ Stock Analysis page.